Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Astrocyte-derived lactosylceramide implicated in multiple sclerosis

Nature Medicine volume 20, pages 1092–1093 (2014)Cite this article

Subjects

Multiple sclerosis (MS) is a demyelinating autoimmune disease of the central nervous system. A new study has shown that the lipid lactosylceramide, produced by astrocytes, contributes to disease progression in a mouse model of MS.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: LacCer signaling in astrocytes promotes CNS inflammation in chronic-progressive EAE.

Katie Vicari/Nature Publishing Group

References

  1. Wingerchuk, D.M. & Carter, J.L. Mayo Clin. Proc. 89, 225–240 (2014).

    Article  Google Scholar 

  2. Nair, A., Frederick, T.J. & Miller, S.D. Cell. Mol. Life Sci. 65, 2702–2720 (2008).

    Article  CAS  Google Scholar 

  3. Simmons, S.B., Pierson, E.R., Lee, S.Y. & Goverman, J.M. Trends Immunol. 34, 410–422 (2013).

    Article  CAS  Google Scholar 

  4. Mayo, L. et al. Nat. Med. 20, 1147–1156 (2014).

    Article  CAS  Google Scholar 

  5. Chatterjee, S., Kolmakova, A. & Rajesh, M. Curr. Drug Targets 9, 272–281 (2008).

    Article  CAS  Google Scholar 

  6. Pannu, R., Singh, A.K. & Singh, I. J. Biol. Chem. 280, 13742–13751 (2005).

    Article  CAS  Google Scholar 

  7. El-Behi, M. et al. Nat. Immunol. 12, 568–575 (2011).

    Article  CAS  Google Scholar 

  8. Kim, R.Y. et al. J. Neuroimmunol. 274, 53–61 (2014).

    Article  CAS  Google Scholar 

  9. Applebee, A. & Panitch, H. Biologics 3, 257–271 (2009).

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Chatterjee, S. et al. Circulation 129, 2403–2413 (2014).

    Article  CAS  Google Scholar 

  11. Fujiwara, H. et al. Biomed. Res. 33, 265–271 (2012).

    Article  CAS  Google Scholar 

  12. Akasako, Y., Nara, K., Nagai, Y. & Hashimoto, Y. Neurosci. Lett. 488, 199–203 (2011).

    Article  CAS  Google Scholar 

  13. Chatterjee, S. & Pandey, A. Biochim. Biophys. Acta 1780, 370–382 (2008).

    Article  CAS  Google Scholar 

  14. Kumagai, T. et al. Biochem. Biophys. Res. Commun. 379, 456–459 (2009).

    Article  CAS  Google Scholar 

  15. Tokuda, N. et al. Glycobiology 23, 1175–1183 (2013).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abdolmohamad Rostami and Bogoljub Ciric are at the Department of Neurology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.,

    Abdolmohamad Rostami & Bogoljub Ciric

Authors
  1. Abdolmohamad Rostami
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bogoljub Ciric
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Abdolmohamad Rostami.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rostami, A., Ciric, B. Astrocyte-derived lactosylceramide implicated in multiple sclerosis. Nat Med 20, 1092–1093 (2014). https://doi.org/10.1038/nm.3719

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm.3719

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing